Last reviewed · How we verify
Recurrent herpes simplex labialis
Approved treatments
- Cortone
- Famvir · Novartis
Famvir works by inhibiting the replication of herpes simplex virus DNA through its action as a nucleoside analog DNA polymerase inhibitor. - Aciclovir · Assistance Publique Hopitaux De Marseille
- Cortef · Generic (originally Merck/Upjohn)
- Zovirax · Ligand Pharms
Acyclovir works by mimicking a building block of DNA to prevent the herpes virus from replicating. - ACYC · Ligand Pharms
Acyc works by binding to a specific target in the body, although its exact mechanism is unknown. - Cortisol · University of Zurich
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Recurrent herpes simplex labialis patent landscape — cliff calendar, originator estates, attackable patents
- Recurrent herpes simplex labialis treatment landscape brief
- Recurrent herpes simplex labialis treatment updates RSS
Frequently asked questions about Recurrent herpes simplex labialis
What drugs treat Recurrent herpes simplex labialis?
Tracked treatments include Cortone, Famvir, Aciclovir, Cortef, Zovirax, ACYC, Cortisol.
What is the treatment for Recurrent herpes simplex labialis?
Standard treatment for Recurrent herpes simplex labialis includes Cortone, Famvir, Aciclovir, Cortef, Zovirax. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Recurrent herpes simplex labialis patent cliff · Recurrent herpes simplex labialis CI report
- Treatment: Cortone
- Treatment: Famvir · Novartis
- Treatment: Aciclovir · Assistance Publique Hopitaux De Marseille
- Treatment: Cortef · Generic (originally Merck/Upjohn)
- Treatment: Zovirax · Ligand Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing